Arixtra and Appetite decreased - a phase IV clinical study of FDA data
Appetite decreased is found among people who take Arixtra, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Arixtra and have Appetite decreased. It is created by eHealthMe based on reports of 9,224 people who have side effects when taking Arixtra from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
9,224 people reported to have side effects when taking Arixtra.
Among them, 115 people (1.25%) have Appetite decreased.
What is Arixtra?
Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,299 Arixtra users for its effectiveness, alternative drugs and more.
What is Appetite decreased?
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 4,149 drugs and 4,202 conditions by eHealthMe.
Number of Arixtra and Appetite decreased reports submitted per year:
Time on Arixtra when people have Appetite decreased *:
Gender of people who have Appetite decreased when taking Arixtra*:
Age of people who have Appetite decreased when taking Arixtra *:
Common drugs people take besides Arixtra *:
Common side effects people have besides Appetite decreased *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Arixtra and have Appetite decreased?Check whether Appetite decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Appetite decreased and when was it recovered:
Expand to all the drugs that have ingredients of fondaparinux sodium:
Alternative drugs to, pros and cons of Arixtra:
- Arixtra (9,299 reports)
Common Arixtra side effects:
Browse all side effects of Arixtra:a b c d e f g h i j k l m n o p q r s t u v w x y z
Appetite decreased treatments and more:
- Appetite decreased (201,423 reports)
COVID vaccines that are related to Appetite decreased:
- Appetite decreased in Moderna COVID Vaccine
- Appetite decreased in Pfizer BioNTech Covid Vaccine
- Appetite decreased in Johnson and Johnson Covid Vaccine
Common drugs associated with Appetite decreased:
All the drugs that are associated with Appetite decreased:
- Appetite decreased (4,149 drugs)
Common conditions associated with Appetite decreased:
All the conditions that are associated with Appetite decreased:
- Appetite decreased (4,202 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fondaparinux sodium (the active ingredients of Arixtra) and Arixtra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hepatic Cyst and Abdominal Pain Upper - 2 seconds ago
- Neuropathy Peripheral and Incisional Hernia - 2 seconds ago
- Ursodeoxycholic Acid and Blood Phosphorus Increased - 3 seconds ago
- Phenazopyridine Hcl and Ultram drug interaction - 8 seconds ago
- High Blood Pressure in Extavia, how severe and when it was recovered? - 9 seconds ago
- Prednisolone and Dacarbazine drug interaction - 9 seconds ago
- Copegus and Renal Failure Acute - 12 seconds ago
- Vertigo Cns Origin and drugs of ingredients of finasteride - 18 seconds ago
- Doxycycline and Ileitis Aggravated - 18 seconds ago
- Altace and Exelon drug interaction - 25 seconds ago